Figure 2. FLE treatment combined with low-dose isotretinoin
A) A 20 year old male patient presenting with baseline acne
severity of IGA 4, previously undergoing topical and tetracycline
therapy without effect, now wishing fast response before summertime. The
patient was started in isotretinoin combined with FLE treatment.B) A 18 year old male patient presenting with baseline acne
severity of IGA 3. The patient was previously treated with topical
treatment, tetracycline without effect, and discontinued isotretinoin
due to elevated levels of CPK, and thereby not eligible to standard dose
of isotretinoin. The patient was started in low-dose isotretinoin
combined with FLE treatment. C) A 20 year old female patient
presenting with baseline acne severity of IGA 4. The patient was
previously started on standard dose of isotretinoin, which was
discontinued due to non-tolerated initial worsening of her acne. Not
being eligible to standard doses of isotretinoin the patient was started
on low-dose isotretinoin and OCP combined with FLE treatment.D) A 18 year old male patient presenting with baseline acne
severity of IGA 3. The patient was previously treated with topical
treatment, tetracycline without effect, and discontinued isotretinoin
due to elevated levels of CPK and transaminase, and thereby not eligible
to standard dose of isotretinoin. The patient was started in low-dose
isotretinoin combined with FLE treatment. Appearance of the skin as
presented at each evaluation; baseline (upper row), week 6 (second row
from top), week 12 (third row from top), week 33 (fourth row from top),
and week 52 (bottom row).